TEAS Plus New Application

DEPO-TESTOSTERONE

Pharmacia & Upjohn Company LLC

Trademark/Service Mark Application, Principal Register

Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number.
PTO Form 1478 (Rev 09/2006)
OMB No. 0651-0009 (Exp 02/28/2021)

Trademark/Service Mark Application, Principal Register

TEAS Plus Application

Serial Number: 90160657
Filing Date: 09/04/2020

NOTE: Data fields with the * are mandatory under TEAS Plus. The wording "(if applicable)" appears where the field is only mandatory under the facts of the particular application.


The table below presents the data as entered.

Input Field
Entered
TEAS Plus YES
MARK INFORMATION
*MARK DEPO-TESTOSTERONE
*STANDARD CHARACTERS YES
USPTO-GENERATED IMAGE YES
LITERAL ELEMENT DEPO-TESTOSTERONE
*MARK STATEMENT The mark consists of standard characters, without claim to any particular font style, size, or color.
REGISTER Principal
APPLICANT INFORMATION
*OWNER OF MARK Pharmacia & Upjohn Company LLC
*MAILING ADDRESS 7000 Portage Road
*CITY Kalamazoo
*STATE
(Required for U.S. applicants)
Michigan
*COUNTRY/REGION/JURISDICTION/U.S. TERRITORY United States
*ZIP/POSTAL CODE
(Required for U.S. and certain international addresses)
49001
*EMAIL ADDRESS XXXX
LEGAL ENTITY INFORMATION
*TYPE LIMITED LIABILITY COMPANY
* STATE/COUNTRY/REGION/JURISDICTION/U.S. TERRITORY WHERE LEGALLY ORGANIZED Delaware
GOODS AND/OR SERVICES AND BASIS INFORMATION
*INTERNATIONAL CLASS 005 
*IDENTIFICATION Pharmaceutical preparations for the treatment of endocrine diseases and disorders
*FILING BASIS SECTION 1(a)
       FIRST USE ANYWHERE DATE At least as early as 12/31/1979
       FIRST USE IN COMMERCE DATE At least as early as 12/31/1979
       SPECIMEN
       FILE NAME(S)
\\TICRS\EXPORT18\IMAGEOUT 18\901\606\90160657\xml1 \ FTK0003.JPG
       SPECIMEN DESCRIPTION photo of the product packaging displaying the mark
ADDITIONAL STATEMENTS INFORMATION
*TRANSLATION
(if applicable)
 
*TRANSLITERATION
(if applicable)
 
*CLAIMED PRIOR REGISTRATION
(if applicable)
 
*CONSENT (NAME/LIKENESS)
(if applicable)
 
*CONCURRENT USE CLAIM
(if applicable)
 
ATTORNEY INFORMATION
NAME Richard A. Friedman
ATTORNEY DOCKET NUMBER T431190
ATTORNEY BAR MEMBERSHIP NUMBER XXX
YEAR OF ADMISSION XXXX
U.S. STATE/ COMMONWEALTH/ TERRITORY XX
FIRM NAME Pfizer Inc.
STREET 235 East 42nd St.
CITY New York
STATE New York
COUNTRY/REGION/JURISDICTION/U.S. TERRITORY United States
ZIP/POSTAL CODE 10017
PHONE 212-733-0086
FAX 212.573.2273
EMAIL ADDRESS DEADLINESIPNYO@Pfizer.com
OTHER APPOINTED ATTORNEY Tiffany Trunko, Heather A. McDonald, Janina Gorbach, and Andrea Christensen
CORRESPONDENCE INFORMATION
NAME Richard A. Friedman
PRIMARY EMAIL ADDRESS FOR CORRESPONDENCE DEADLINESIPNYO@Pfizer.com
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES) NOT PROVIDED
FEE INFORMATION
APPLICATION FILING OPTION TEAS Plus
NUMBER OF CLASSES 1
APPLICATION FOR REGISTRATION PER CLASS 225
*TOTAL FEES DUE 225
*TOTAL FEES PAID 225
SIGNATURE INFORMATION
* SIGNATURE /RAF/
* SIGNATORY'S NAME Richard A. Friedman
* SIGNATORY'S POSITION Attorney of Record
SIGNATORY'S PHONE NUMBER 212-733-0086
* DATE SIGNED 09/04/2020



Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number.
PTO Form 1478 (Rev 09/2006)
OMB No. 0651-0009 (Exp 02/28/2021)


Trademark/Service Mark Application, Principal Register

TEAS Plus Application

Serial Number: 90160657
Filing Date: 09/04/2020

To the Commissioner for Trademarks:

MARK: DEPO-TESTOSTERONE (Standard Characters, see mark)
The literal element of the mark consists of DEPO-TESTOSTERONE. The mark consists of standard characters, without claim to any particular font style, size, or color.
The applicant, Pharmacia & Upjohn Company LLC, a limited liability company legally organized under the laws of Delaware, having an address of
      7000 Portage Road
      Kalamazoo, Michigan 49001
      United States
      XXXX

requests registration of the trademark/service mark identified above in the United States Patent and Trademark Office on the Principal Register established by the Act of July 5, 1946 (15 U.S.C. Section 1051 et seq.), as amended, for the following:

For specific filing basis information for each item, you must view the display within the Input Table.
International Class 005:  Pharmaceutical preparations for the treatment of endocrine diseases and disorders

Use in Commerce: The applicant is using the mark in commerce on or in connection with the identified goods/services. The applicant attaches, or will later submit, one specimen as a JPG/PDF image file showing the mark as used in commerce on or in connection with any item in the class of listed goods/services, regardless of whether the mark itself is in the standard character format or is a stylized or design mark. The specimen image file may be in color, and the image must be in color if color is being claimed as a feature of the mark.

In International Class 005, the mark was first used by the applicant or the applicant's related company or licensee predecessor in interest at least as early as 12/31/1979, and first used in commerce at least as early as 12/31/1979, and is now in use in such commerce. The applicant is submitting one(or more) specimen(s) showing the mark as used in commerce on or in connection with any item in the class of listed goods/services, consisting of a(n) photo of the product packaging displaying the mark.
Specimen File1



The owner's/holder's proposed attorney information: Richard A. Friedman. Other appointed attorneys are Tiffany Trunko, Heather A. McDonald, Janina Gorbach, and Andrea Christensen. Richard A. Friedman of Pfizer Inc., is a member of the XX bar, admitted to the bar in XXXX, bar membership no. XXX, and the attorney(s) is located at
      235 East 42nd St.
      New York, New York 10017
      United States
      212-733-0086(phone)
      212.573.2273(fax)
      DEADLINESIPNYO@Pfizer.com
The docket/reference number is T431190.
Richard A. Friedman submitted the following statement: The attorney of record is an active member in good standing of the bar of the highest court of a U.S. state, the District of Columbia, or any U.S. Commonwealth or territory.
The applicant's current Correspondence Information:
      Richard A. Friedman
       PRIMARY EMAIL FOR CORRESPONDENCE: DEADLINESIPNYO@Pfizer.com
       SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES): NOT PROVIDED


Requirement for Email and Electronic Filing: I understand that a valid email address must be maintained by the applicant owner/holder and the applicant owner's/holder's attorney, if appointed, and that all official trademark correspondence must be submitted via the Trademark Electronic Application System (TEAS).
A fee payment in the amount of $225 has been submitted with the application, representing payment for 1 class(es).

Declaration

Declaration Signature

Signature: /RAF/   Date: 09/04/2020
Signatory's Name: Richard A. Friedman
Signatory's Position: Attorney of Record
Signatory's Phone Number: 212-733-0086
Payment Sale Number: 90160657
Payment Accounting Date: 09/04/2020

Serial Number: 90160657
Internet Transmission Date: Fri Sep 04 16:47:19 ET 2020
TEAS Stamp: USPTO/FTK-XXX.XXX.XX.XX-2020090416471974
9732-90160657-7503b29b3d18f5c753e5b5a401
b3898dcedaecac1fbf387aff5faef1cedb7cbe0f
4-DA-47198355-20200904145121951456

TEAS Plus New Application [image/jpeg]

TEAS Plus New Application [image/jpeg]


uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed